POC Diagnostics – our new study reveals trends, R&D progress, and predicted revenues
Where is the POC Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 289-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing POC Diagnostics market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 7 POC Diagnostics Types, each forecasted at a global level.
POC Diagnostics, by Product Type
• Blood Glucose
• Infectious Diseases
• Rapid Coagulation
• Rapid Cardiac Marker
• Cholesterol
• Pregnancy
• Other
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 15 leading national markets:
• The US
• Germany
• The UK
• Italy
• Spain
• France
• Switzerland
• Belgium
• The Netherlands
• Japan
• China
• India
• Brazil
• Russia
• South Africa
• RoW
The report also includes profiles and for some of the leading companies in the POC Diagnostics market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Japan in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth
Overall world revenue for POC Diagnostics will surpass $5bn in 2027, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the POC Diagnostics Market report helps you
In summary, our 289-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the POC Diagnostics market with forecasts for 7 Types of POC testing – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 15 key national markets – See forecasts for the POC Diagnostic market in the US, Japan, Germany, France, the UK, Italy, Spain, Belgium, The Netherlands, Switzerland, Brazil, China, India, South Africa and Russia
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for 4 of the major companies involved in the POC Diagnostics market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the POC Diagnostics market and leading companies. You will find data, trends and predictions.
Get our report today POC Diagnostic Systems Market Forecast 2017-2027: Analysis of POC Diagnostics Market Forecast 2017-2027: Revenue Prospects by Product (Blood Glucose, Infectious Diseases, Rapid Coagulation, Rapid Cardiac Marker, Cholesterol, Pregnancy, Other) and Major National Markets with an Assessment of Leading Companies.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Global POC Diagnostics Market Overview
1.2 Global POC Diagnostics Market Segmentation
1.3 Overview of Findings
1.4 Structure of the Report
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Who is This Report For?
1.9 Methodology
1.10 Frequently Asked Questions (FAQ)
1.11 Associated Visiongain Reports
1.12 About Visiongain
2. Introduction to In Vitro and POC Diagnostics
2.1 An Introduction to In Vitro Diagnostics
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 IVD Classifications in Australia
2.2.3 EDMA Classification
2.2.3.1 Clinical Chemistry
2.2.3.2 Immunochemistry
2.2.3.3 Haematology
2.2.3.4 Microbiology
2.2.3.5 Genetic Testing
2.2.3.6 Point Of Care Diagnostics: The Dominating Segment
2.3 Diagnostics Regulation of the IVD and POC Market
2.3.1 FDA and CLIA Regulation of IVD and POC Tests
2.3.2 Regulation of IVD/POC Diagnostics in the EU: The EC (European Commission) Classification
2.4 Regulation for In Vitro Diagnostics and POC Diagnostics
2.4.1 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.2 Device Excise Tax: A Threat to the Diagnostics Manufacturers
2.5 Uses of Point of Care (POC) Diagnostics
2.6 Advantages and Disadvantages of POC Diagnostics
3. The In Vitro Diagnostics Market, 2016
3.1 The Global In Vitro Diagnostics by Segment, 2016
3.2 The Global In Vitro Diagnostics Market Sales Forecast, 2016-2027
3.2.1 POC Diagnostics to Drive the Global IVD Market in the Next 10 Years
3.3 The Global Clinical Diagnostics Market Forecast, 2017-2027
3.4 The Global Point of Care Diagnostics Market: Sales Forecast 2017-2027
3.4.1 The Drive of Personalised Medicine
4. The Global Point of Care Diagnostics Market, 2016-2027
4.1 Market Overview, 2016
4.1.1 Self-testing Constituted the Largest Segment in the POC Market by the Point of Delivery
4.2 Point of Care Diagnostics Market Segmentation
4.3 POC Diagnostics Market, by Product 2017-2027
4.3.1 Market Overview, 2016
4.3.1.1 Scope of the Point of Care Diagnostics Market
4.3.1.2 Which Point of Care Diagnostic Segment Holds the Greatest Potential?
4.3.2 Market Forecast 2017-2027
4.3.3 Market Share of POC Diagnostics by Product
4.3.4 Blood Glucose Testing: Market Forecast, 2016-2027
4.3.5 Infectious Diseases Testing: Market Forecast, 2016-2027
4.3.6 Rapid Coagulation Testing: Market Forecast, 2016-2027
4.3.7 Rapid Cardiac Marker Testing: Market Forecast, 2016-2027
4.3.8 Cholesterol Testing: Market Forecast, 2016-2027
4.3.9 Pregnancy Testing: Market Forecast, 2016-2027
4.3.10 Other Testing: Market Forecast, 2016-2027
4.3.10.1 Cancer Diagnostics To Fuel Market Growth
4.3.10.2 The Haematology Market Will Be Driven by Blood Gas Tests
4.3.10.3 A Recently Discovered Biomarker for Sepsis Can Set The Potential For A Future Rapid Blood Test
4.3.10.4 Successful Clinical Study of Quo-Test A1c POCT Analyser For Diabetes Screening
5. Global POC Blood Glucose Testing Market, 2017-2027
5.1 Market Overview, 2016
5.2 Global POC Blood Glucose Testing Market, 2016
5.3 POC Blood Glucose Testing Market Forecast, 2016-2027
5.3.1 POC Blood Glucose Testing Market, By Type of Meter
5.3.2 POC Blood Glucose Testing Market, By Type of Meter
5.3.2.1 POC Blood Glucose Testing Devices Currently Available in the Market, 2016
5.3.3 Leading Regional Markets in the POC Blood Glucose Testing Market, 2016
5.3.4 Leading Companies in the POC Blood Glucose Testing Market, 2016
5.3.4.1 Other Companies in the POC Blood Glucose Testing Market: Recent Advances
5.3.5 Market Prospects to 2027: Which Product Will Lead the Market?
5.3.5.1 Advantages and Disadvantages of the Current CGM Tests in the Market
5.4 Drivers and Restraints for the POC Blood Glucose Testing Market, 2017-2027
6. Global POC Coagulation Testing Market, 2017-2027
6.1 Market Overview, 2016
6.2 Global POC Coagulation Testing Market in 2016
6.2.1 PT/INR Monitoring is the Largest Segment in the POC Coagulation Testing Market
6.3 Products Available in the POC Coagulation Testing Market, 2016
6.3.1 Patient Self-Testing is the Fastest Growing Segment
6.4 POC Coagulation Testing Market Segment by Components
6.4.1 Test Strips Generate 85.8% of the Sales in the PT/INR POC Testing Market
6.5 POC Coagulation Testing Market by Type of Drug
6.5.1 Anticoagulants
6.5.2 Heparins
6.5.3 Vitamin K Antagonists
6.5.4 Direct Thrombin Inhibitors
6.5.5 Direct Factor Xa Inhibitors
6.6 The POC Coagulation Testing Market by Regions, 2016
6.7 POC Coagulation Testing Market Forecast 2016-2027
6.8 Leading Companies in the POC Coagulation Testing Market, 2016
6.8.1 Roche Dominated the POC Coagulation Testing Market with CoaguChek XS System in 2016
6.8.2 Market Prospects to 2027: Who Will Be The Leading Product?
6.9 Drivers and Restraints for the POC Coagulation Testing Market, 2017-2027
7. Global Cardiac Marker Diagnostic Testing Market, 2017-2027
7.1 Market Overview, 2016
7.2 The Global Cardiac Marker Diagnostic Testing Market 2016
7.3 Cardiac Marker Diagnostic Testing Market Forecast 2017-2027
7.3.1 Leading Regional Markets in the Cardiac Marker Diagnostic Testing, 2016
7.3.2 Leading Companies in the Cardiac Marker Diagnostic Testing Market, 2016
7.3.3 Cardiac Marker Diagnostic Testing Market: Leading Products
7.3.4 Which Company is Dominating the Market?
7.3.5 A Leading Product: Abbott’s i-STAT
7.4 Drivers and Restraints for the Cardiac Marker Diagnostic Testing Market, 2017-2027
7.4.1 Challenges for the New Entrants in the Cardiac Markers Diagnostic Testing Market
8. Global POC Infectious Diseases Testing Market, 2017-2027
8.1 Market Overview, 2016
8.2 Global POC Infectious Diseases Testing Market, 2016
8.2.1 Breakdown of the POC Infectious Diseases Testing Market by Diseases, 2016
8.2.1.1 Influenza/Flu
8.2.1.2 HIV
8.2.1.3 Hepatitis
8.2.1.4 Tuberculosis
8.2.1.5 Sexually Transmitted Diseases
8.3 The POC Infectious Diseases Testing Market: Leading Products 2016
8.3.1 HIV Leading POC Diagnostics Products, 2016
8.3.1.1 HIV Diagnostics Kits Approved by the FDA, 2016
8.3.1.2 HIV POC Tests Pipeline, 2016
8.3.1.3 Driving Factors for Growth of HIV Rapid Testing: Past and Future
8.3.2 The Hepatitis POC Testing Market
8.3.2.1 First Rapid HCV Test Approved in the US
8.3.2.2 Driving Factors for Growth of Hepatitis Rapid Testing
8.3.3 The Influenza POC Testing Market and Leading Companies, 2016
8.4 POC Diagnostics Infectious Diseases Recent Trends
8.4.1 OraQuick Marker, OraSure Technologies: First OTC Home-Use Rapid HIV Test Approved by the FDA
8.4.2 Determine HIV-1/2 Ag/Ab Combo Test, Alere: First Rapid Diagnostic Test to Detect Both HIV-1 Antigen And HIV-1/2 Antibodies
8.5 Leading Regional Markets in the POC Infectious Diseases Testing
8.5.1 Infectious Diseases POC Testing: Regional Markets in 2016
8.6 Infectious Diseases POC Testing Market: Leading Companies 2016
8.7 The POC Infectious Diseases Testing Market Forecast, 2017-2027
8.8 Drivers and Restraints for the POC Infectious Diseases Testing Market, 2017-2027
9. Global POC Pregnancy Testing Market, 2017-2027
9.1 Market Overview, 2016
9.2 Global POC Pregnancy Testing Market, 2016
9.3 The POC Pregnancy Testing Market Forecast 2017-2027
9.3.1 The POC Pregnancy Testing Market: Leading Products 2016
9.3.2 Leading Companies in the POC Pregnancy Testing Market, 2016
9.4 Drivers and Restraints for the POC Pregnancy Testing Market, 2016-2027
10. Global POC Cholesterol Testing Market, 2017-2027
10.1 Market Overview, 2016
10.2 The Global POC Cholesterol Testing Market in 2016
10.3 The POC Cholesterol Testing Market Forecast 2017-2027
10.3.1 POC Cholesterol Testing Biomarkers: Overview
10.3.2 The POC Cholesterol Testing Market by Components
10.3.3 Recent Developments in the POC Cholesterol Testing Market, 2016
10.3.3.1 Roche’s Accutrend Plus
10.3.4 POC Cholesterol Testing Market: Considerations in Production
10.4 Drivers and Restraints for the POC Cholesterol Testing Market, 2016-2027
11. Leading National Markets 2017-2027
11.1 Geographical Breakdown of the World POC Diagnostics Market
11.2 Global POC Diagnostics Market: Regional Forecast 2017-2027
11.3 How Will Regional Market Shares Change to 2027?
11.4 The U.S. POC Diagnostics Market 2017-2027
11.4.1 Healthcare Expending in the US
11.4.2 The US POC Diagnostics Market Dynamics: Drivers and Restraints
11.4.3 The U.S. POC Diagnostics Market Forecast 2017-2027
11.5 The Leading European POC Diagnostics Market 2017-2027
11.5.1 German POC Diagnostics Market Forecast 2017-2027
11.5.2 UK POC Diagnostics Market Forecast 2017-2027
11.5.3 French POC Diagnostics Market Forecast 2017-2027
11.5.4 Spanish POC Diagnostics Market Forecast 2017-2027
11.5.5 Italian POC Diagnostics Market Forecast 2017-2027
11.5.6 The Netherlands POC Diagnostics Market Forecast 2017-2027
11.5.7 Belgian POC Diagnostics Market Forecast 2017-2027
11.5.8 Swiss POC Diagnostics Market Forecast 2017-2027
11.6 The Japanese POC Diagnostics Market 2017-2027
11.6.1 The Japanese POC Diagnostics Market Forecast 2017-2027
11.7 The BRICS Nations POC Diagnostics Market 2017-2027
11.7.1 The Chinese POC Diagnostics Market 2017-2027
11.7.1.1 The Chinese POC Diagnostics Market Forecast 2017-2027
11.7.2 The Indian POC Diagnostics Market 2017-2027
11.7.2.1 The Indian POC Diagnostics Market Forecast 2017-2027
11.7.3 The Brazilian POC Diagnostics Market 2017-2027
11.7.3.1 The Brazilian POC Diagnostics Market Forecast 2017-2027
11.7.4 The Russian POC Diagnostics Market 2017-2027
11.7.4.1 The Russian POC Diagnostics Market Forecast 2017-2027
11.7.5 The South African POC Diagnostics Market 2017-2027
11.7.5.1 The South African POC Diagnostics Market Forecast 2017-2027
11.8 The Rest of the World POC Diagnostics Market 2017-2027
11.8.1 The RoW POC Diagnostics Market Forecast 2017-2027
11.9 Further Insights: Point of Care Diagnostics Approach for Developing Countries
12. Leading Companies in the POC Diagnostics Market
12.1 F. Hoffmann-La Roche AG
12.1.1 Global Presence
12.1.2 Roche: POC Diagnostics Product Portfolio
12.1.3 Roche: Planned Key Product Launches, 2017
12.1.4 Roche: POC Diagnostics Financial Overview
12.1.5 Roche: POC Diagnostics Recent Developments
12.2 Abbott
12.2.1 Abbott: POC Diagnostics Product Portfolio
12.2.2 Abbott: POC Diagnostics Financial Overview
12.2.3 Abbott: POC Diagnostics Recent Developments
12.3 Siemens Healthineers
12.3.1 Siemens Healthineers: POC Diagnostics Product Portfolio
12.3.2 Siemens Healthineers: POC Diagnostics Financial Overview
12.3.3 Siemens Healthineers: POC Diagnostics Recent Developments
12.4 Alere Inc.
12.4.1 Alere Inc.: POC Diagnostics Product Portfolio
12.4.2 Alere Inc.: Financial Overview
12.4.3 Alere Inc.: POC Diagnostics Recent Developments
13. POC Diagnostics Market, Qualitative Analysis, 2017-2027
13.1 Introduction
13.2 Drivers and Restraints for the POC Diagnostics Market
13.2.1 Commercial Drivers
13.2.2 Commercial Restraints
13.3 PESTEL Analysis
13.3.1 Political Factors
13.3.2 Economic Factors
13.3.3 Socio-Cultural Factors
13.3.4 Technological Factors
13.3.5 Environmental Factors
13.3.6 Legal Factors
13.4 POC Diagnostics Market: Porters Five Forces Analysis, 2017-2027
13.4.1 Bargaining Power of Supplier
13.4.2 Bargaining Power of Buyer
13.4.3 Competitive Rivalry
13.4.4 Threat of New Entrants
13.4.5 Threat of Substitutes
13.5 POC Diagnostics Market: SWOT Analysis, 2017-2027
13.5.1 Strengths
13.5.1.1 Aids in rapid medical intervention
13.5.2 Weaknesses
13.5.2.1 Awaiting Reimbursement Options
13.5.3 Opportunities
13.5.3.1 Expanding population base
13.5.4 Threats
13.5.4.1 Unmet Needs in Low-Middle Income Countries
14. Conclusions
14.1 The World POC Diagnostics Market in 2016 and 2017
14.2 Current Leading POC Diagnostics Segments
14.3 Leading POC Diagnostics Companies
14.4 Leading Regional Markets
14.5 World POC Diagnostics Market Forecast 2017-2027
14.6 The Future of the POC Diagnostics Market
15. Glossary
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Figures
Figure 1.1 Global POC Diagnostics Market Segmentation Overview, 2016
Figure 3.1 Global IVD Market Share (%) by Segment, 2016
Figure 3.2 Global IVD Market Revenues ($bn) for Clinical Diagnostics and POC Diagnostics Segments, 2016
Figure 3.3 Global IVD Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 3.4 The IVD Diagnostics Market Forecast: Revenue ($bn), by Segments, 2016-2027
Figure 3.5 The Clinical Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 3.6 The Global POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 4.1 The POC Diagnostics Market: Shares (%) by Segments, 2016
Figure 4.2 World POC Diagnostics Market Forecast: Revenues ($bn), by Segment, 2016-2027
Figure 4.3 Scope of The POC Diagnostics Market: Revenue ($bn) and CAGR (%), by Segments, 2016
Figure 4.4 Global POC Diagnostics Market Forecast, By Product: Revenue ($bn) and AGR (%), 2016-2027
Figure 4.5 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2016
Figure 4.6 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2021
Figure 4.7 Global POC Diagnostics Market Forecast, By Product: Market Shares (%), 2027
Figure 5.1 The Global POC Blood Glucose Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 5.2 Market Shares (%) of Fingerstick Testing and CGM Devices in the POC Blood Glucose Monitoring Market, 2016
Figure 5.3 Market Shares (%) of Devices, Test Strips and Other Devices in the POC Blood Glucose Testing Market, 2016
Figure 5.4 Market Shares (%) of Leading National Markets in the POC Blood Glucose Testing Market, 2016
Figure 5.5 POC Blood Glucose Testing Market: Drivers and Restraints 2017-2027
Figure 6.1 The PT/INR POC Testing Market by Point of Use, Market Share (%), 2016
Figure 6.2 The POC Diagnostics Market: Shares (%) by Segments, 2016
Figure 6.3 The Global POC Coagulation Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 6.4 POC Coagulation Testing Market: Drivers and Restraints 2017-2027
Figure 7.1 Global Cardiac Marker Diagnostic Testing Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 7.2 Cardiac Marker Diagnostic Testing Market: Drivers and Restraints, 2017-2027
Figure 8.1 The POC Diagnostics Market: Shares (%) by Segments, 2016
Figure 8.2 Global POC Infectious Diseases Testing Market Forecast: Revenue ($bn), AGR (%), 2016-2027
Figure 8.3 POC Infectious Diseases Testing Market: Drivers and Restraints, 2016-2027
Figure 9.1 Global POC Pregnancy Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 9.2 Global IVD Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 10.1 POC Cholesterol Testing Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 10.2 The POC Cholesterol Testing Market: Drivers and Restraints, 2016-2027
Figure 11.1 Global POC Diagnostics Market, By Region: Revenues ($bn), 2016
Figure 11.2 Global POC Diagnostics Market, By Region: Revenues ($bn), 2017
Figure 11.3 Global POC Diagnostics Market, By Region: Revenue ($bn), 2016-2027
Figure 11.4 Global POC Diagnostics Market, By Region: Market Shares (%), 2016
Figure 11.5 Global POC Diagnostics Market, By Region: Market Shares (%), 2021
Figure 11.6 Global POC Diagnostics Market, By Region: Market Shares (%), 2027
Figure 11.7 US POC Diagnostics Market: Drivers and Restraints, 2016-2027
Figure 11.8 U.S. POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.9 European POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.10 European POC Diagnostics Market: Market Shares (%) by National Market, 2016
Figure 11.11 European POC Diagnostics Market: Market Shares (%) by National Market, 2021
Figure 11.12 European POC Diagnostics Market: Market Shares (%) by National Market, 2027
Figure 11.13 German POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.14 UK POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.15 French POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.16 Spanish POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.17 Italian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.18 The Netherlands POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.19 Belgian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.20 Swiss POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.21 Japanese POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.22 BRICS POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.23 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2016
Figure 11.24 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2022
Figure 11.25 The BRICS Nations POC Diagnostics Market Shares (%), by Country, 2027
Figure 11.26 Chinese POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.27 Indian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.28 Brazilian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.29 Russian POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.30 South African POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 11.31 RoW POC Diagnostics Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
Figure 12.1 Roche: Diagnostics Revenue ($bn) and AGR (%), 2016-2027
Figure 12.2 Abbott: POC Diagnostics Revenue ($bn) and AGR (%), 2016-2027
Figure 12.3 Siemens Healthineers: Revenue ($bn) and AGR (%), 2016-2027
Figure 12.4 Alere Inc. Revenue Shares (%), by Business Segment, 2016
Figure 12.5 Alere Professional Diagnostics Segment: Revenue Shares (%), by Group, 2016
Figure 12.6 Alere Inc.: Revenue ($bn) and AGR (%), 2016-2027
Figure 13.1 POC Diagnostics Market: Drivers and Restraints 2017-2027
Figure 13.2 Porter’s Five Forces Analysis of the POC Diagnostics Market, 2017-2027
List of Tables
Table 1.1 POC Diagnostics Market Forecast, By Product Revenue ($bn), AGR (%), CAGR (%), 2017-2027
Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017
Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017 (continued)
Table 2.1 Types of Genetic In Vitro Diagnostic Tests Currently Available, 2017 (continued)
Table 2.2 Advantages and Disadvantages of POC Diagnostics, 2017
Table 3.1 The IVD Diagnostics Market: Revenue ($bn) and Market Shares (%) by Segments, 2016
Table 3.2 The IVD Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 3.3 The IVD Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%) by Segments, 2016-2027
Table 3.4 The Clinical Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2027
Table 3.5 The POC Diagnostics Market Forecast: Revenue ($bn), AGR (%) and CAGR (%),2016-2027
Table 4.1 The IVD Diagnostics Market: Revenue ($bn) and Market Shares (%) by Type of Delivery, 2016
Table 4.2 The POC Diagnostics Market: Revenue ($bn) and Market Shares (%) by Segments, 2016
Table 4.3 Global POC Diagnostics Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Segment, 2016-2027
Table 5.1 Global Blood Glucose Testing Market, Revenue ($bn) and Share (%), 2016
Table 5.2 POC Blood Glucose Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 5.3 Global POC Blood Glucose Testing Devices Market, Revenue ($bn) and Shares (%), by Type of Meter, 2016
Table 5.4 Global POC Blood Glucose Testing Devices Market, Revenue ($bn) and Shares (%), by Components, 2016
Table 5.5 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (A), 2016
Table 5.6 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (B-F), 2016
Table 5.7 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (F-N), 2016
Table 5.8 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (N-T), 2016
Table 5.9 Retail Prices of the Blood Glucose Meters and Strips Currently Available in the Market, by Company (T-Z), 2016
Table 5.10 Leading National Markets for the POC Blood Glucose Testing Market, Revenue ($bn) and Shares (%),2016
Table 5.11 Diabetes Care Business Segment, Revenue ($bn) and Shares (%), by Leading Companies, 2016
Table 5.12 List of Some Other Companies in the POC Blood Glucose Testing Market, 2016
Table 5.13 Advantages and Disadvantages of the Currently Available CGM, by Product, 2016
Table 5.13 Advantages and Disadvantages of the Currently Available CGM, by Product, 2016 (continued)
Table 6.1 Global Rapid Coagulation Testing Market, Revenue ($bn) and Share (%), 2016
Table 6.2 List of Some Products in the POC Coagulation Testing Market for Self Testing and Professional Testing, 2016
Table 6.3 The PT/INR POC Testing Market, Revenue ($bn) and Shares (%), by Point of Use, 2016
Table 6.4 The Price of Some PT/INR POC Testing Systems ($), 2016
Table 6.5 The PT/INR POC Testing Market, Revenue ($m) and Shares (%), by Components, 2016
Table 6.6 POC Rapid Coagulation Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 7.1 Global Cardiac Marker Diagnostic Testing Market, Revenue ($bn) and Share (%), 2016
Table 7.2 Time to Elevation for Some Cardiac Markers, 2016
Table 7.3 Clinical Use of the Cardiac Biomarkers, 2017
Table 7.4 POC Rapid Cardiac Marker Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 7.5 Leading Products in the Cardiac Marker Diagnostic Testing Market, by Company, 2016
Table 8.1 Global POC Infectious Diseases Testing Market, Revenue ($bn) and Share (%), 2016
Table 8.2 Global POC Infectious Diseases Testing Market, Revenue ($bn) and Share (%), 2016
Table 8.3 Strengths and Limitations of Some Leading Products in the HIV Rapid Testing Market, 2016
Table 8.4 Currently Approved HIV Diagnostic Kits Through Premarket Applications (PMAs), by Date of FDA Approval, 2017
Table 8.4 Currently Approved HIV Diagnostic Kits Through Premarket Applications (PMAs), by Date of FDA Approval, 2017 (continued)
Table 8.5 HIV RDTs For Self-Testing In The Pipeline, 2017
Table 8.6 List of Some Products in the POC Hepatitis Testing Market, 2016
Table 8.7 List of Some Products in the Rapid Influenza Testing Market, 2016
Table 8.8 POC Infectious Diseases Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 9.1 Global POC Pregnancy Testing Market, Revenue ($bn) and Share (%), 2016
Table 9.2 POC Pregnancy Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 10.1 Global POC Cholesterol Testing Market, Revenue ($bn) and Share (%), 2016
Table 10.2 POC Cholesterol Testing Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.1 Global POC Diagnostics Market, By Region: Revenues ($bn) and Market Share (%) 2016 and 2017
Table 11.2 Global POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.3 U.S. POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.4 European POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.4 European POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027 (continued)
Table 11.5 German POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.6 UK POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.7 French POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.8 Spanish POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.9 Italian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.10 The Netherlands POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.11 Belgian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.12 Swiss POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.13 Japanese POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.14 BRICS POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.15 China POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.16 Indian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.17 Brazilian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.18 Russian POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.19 South African POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 11.20 RoW POC Diagnostics Market Forecast, By Region: Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 12.1 F. Hoffmann-La Roche AG: Overview, 2017
Table 12.2 Roche Diagnostics: Key Product Launches Planned for 2017
Table 12.3 Roche Diagnostics: Revenue ($m) and Revenue Share (%), by Business Area, 2016
Table 12.4 Roche Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 12.5 Abbott: Overview, 2017
Table 12.6 Abbott Diagnostics: Business Highlights, 2016
Table 12.7 Abbott Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 12.8 Siemens Healthineers: Overview, 2017
Table 12.9 Siemens Healthineers POC Diagnostics Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 12.10 Alere Inc.: Overview, 2017
Table 12.11 Alere Inc.: Product Portfolio (Cardiometabolic), 2017
Table 12.12 Alere Inc.: Product Portfolio (Cardiometabolic, Infectious Diseases), 2017
Table 12.13 Alere Inc.: Product Portfolio (Infectious Diseases), 2017
Table 12.14 Alere Inc.: Product Portfolio (Infectious Diseases cont.) 2017
Table 12.15 Alere Inc.: Product Portfolio (Toxicology), 2017
Table 12.16 Alere Inc.: Revenue ($bn) and Change (%), by Business Area, 2015 & 2016
Table 12.17 Alere Inc. Revenue ($bn), AGR (%), CAGR (%), 2016-2027
Table 13.1 POC Diagnostics Market: SWOT Analysis, 2017-2027
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
